Bock, Paul R <br/><br/>
[Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].  [electronic resource] 

 -  Arzneimittel-Forschung  2004 
 - 456-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0004-4172 
<br/><br/><label>Standard No.: </label>10.1055/s-0031-1296999  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cohort Studies<br/>Disease Progression<br/>Endpoint Determination<br/>Female<br/>Humans<br/>Middle Aged<br/>Mistletoe<br/>Phytotherapy--adverse effects<br/>Plant Extracts--therapeutic use<br/>Proportional Hazards Models<br/>Survival Analysis